Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

413.16 19.04 −4.41%
Market cap
$51.9B
P/E
38.8×
Fwd P/E
42.9×
Dividend yield
0.86%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100

Humana Inc. (HUM) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Humana Inc. (HUM) trades at a P/S ratio of 0.3×. Over the past ten years it has ranged from 0.2× (March 2026) to 0.9× (November 2018); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.2× (8.43%)
FY2024 0.3× (52.54%)
FY2023 0.5× (19.65%)
FY2022 0.7× (5.19%)
FY2021 0.7× 2.22%
FY2020 0.7× (7.16%)
FY2019 0.8× 9.41%
FY2018 0.7× 2.34%
FY2017 0.7× 24.59%
FY2016 0.5× 10.46%

Quarterly newest first

Period P/S ratio Change
Jun 2026 0.3× 115.25%
Mar 2026 0.2× (36.07%)
Dec 2025 0.2× (3.92%)
Sep 2025 0.2× 3.43%
42 more quarters

Against its own ten years

Low 0.2× High 0.9×
Ten-year median 0.6×
Current reading's percentile 19

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on HUM